Skip to main content
. 2020 Oct 14;9(10):695. doi: 10.3390/antibiotics9100695

Figure 1.

Figure 1

Recently discovered thienopyridines (A,B) and pyrimidine–based compounds (C,D) as bacterial type II topoisomerase inhibitors and the design of the target heterocyclic ring system.